what glp 1 does serena williams take EXCLUSIVE: has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an exclusive TODAY interview., The 23-time Grand Slam champion Inside Serena Williams' 14kg weight

The significant weight reduction seen with these medications has made them valuable tools in managing obesity-related complications, as reflected in NICE guidance and technology appraisals for their use in both diabetes (NG28) and weight management

Convenience While oral Wegovy and Foundayo are both pills, theyre administered differently, which may make Foundayo easier to stick with

Phase 2 results at 48 weeks (Jastreboff et al., NEJM 2023): Phase 3 TRIUMPH-4 at 68 weeks (Lilly Press Release, Dec 2025): The 12 mg dose produced 28.7% body weight loss, an average of 71.2 lbs from a 248.5 lb baseline

If a product claims GLP-1 effects but contains no GLP-1 compounds and uses a delivery method with no proven efficacy, the claims do not match the science

Do not start one without medical guidance

Research Overview Sema is a long-acting GLP-1 receptor agonist that has generated significant scientific interest due to its prolonged receptor activation and its role in metabolic signaling pathways